CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti-CD30 CAR T-cell therapy.
Marques-Piubelli ML, Kim DH, Medeiros LJ, Lu W, Khan K, Gomez-Bolanos LI, Rodriguez S, Parra ER, Ok CY, Aradhya A, Solis LM, Nieto YL, Steiner R, Ahmed S, Vega F.
Marques-Piubelli ML, et al. Among authors: khan k.
Histopathology. 2023 Jul;83(1):143-148. doi: 10.1111/his.14910. Epub 2023 Mar 30.
Histopathology. 2023.
PMID: 36994939